Skip to content

Graves' disease may be a risk for patients starting ART with a low CD4 cell count who then have good immune restoratation

Donors must keep promise to support children, Save the Children urges

HIV prevalence amongst IDUs in England and Wales at highest level since 1992

Management of HIV and hepatitis B or C co-infection in resource-limited settings

Atazanavir/ritonavir as potent over two years as Kaletra, but has better side-effects profile

Study finds evidence linking fat loss to the activity of the nervous system

Prevention alongside treatment only way to contain HIV epidemic, scientific modelling finds

US launches drive to find better HIV treatments for children in poorest countries

The high cost of non-antiretroviral medicines used by people with AIDS in Côte d’Ivoire